Aims-To evaluate two of the recent methods of coating microtitre plates in the enzyme linked immunosorbent assay (ELISA) for detecting human antibodies against meningococcal capsular polysaccharides A and C with a view to validating a specific meningococcal antibody assay for routine clinical use. Methods-Two four-layer ELISA protocols were standardised: one method utilised meningococcal polysaccharides conjugated to poly-L-lysine polypeptide for coating the microtitre plates; another used polysaccharides mixed with methylated human serum albumin (mHSA). Titration curves were plotted for the ELISAs and the squared Pearson correlation coefficient (R2) was used to determine the degree of accuracy of fit of the curves. Specificity tests were performed by inhibition and adsorption studies. Results-Both methods gave good titration curves with a high R2 of >0-98, indicating a high degree of accuracy in forming the curves. The titration end point after vaccination, obtained by the mHSA method, was 20 times higher, however, than that obtained by the poly-L-lysine method. Specificity tests showed that in the ELISA using polysaccharide/poly-L-lysine, antibody activity of a pre-vaccination serum sample was inhibited by 37%, and of post-vaccination serum by 50%/ with 1000-fold excess antigen. Antibody activity (postvaccination) was reduced by 51% and 59o/o, respectively, by adsorption with antigen-coated Sepharose beads or adsorption with suspensions of killed meningococci. In contrast, antibody activity of a pre-vaccination serum was inhibited by 60% and a post-vaccination serum by 90% in ELISA employing polysaccharides mixed with mHSA. Reproducibility was better with the use of methylated human serum albumin than with poly-L-lysine; the former showed intrabatch and interbatch coefficients of variation of 4% and 2%, respectively, compared with 43% (intrabatch) and 16% (interbatch) obtained with the poly-Llysine. Conclusion-It is concluded that the antibody assay using meningococcal polysaccharides groups A and C mixed with mHSA is much better than that using polysaccharides coupled with poly-Llysine.
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The plates were washed five times after each step and the assay developed with 100 l OPD substrate per well, as described before.
STATISTICAL ANALYSIS AND INTERPRETATION OF ASSAYS
Graphs of the absorbance against loglox of the serum dilution were plotted using a standard computer program. These sigmoid scatter curves were expected to follow third order polynomial equations and therefore computerised methods for determining adequacy of curve fit were used. The squared Pearson correlation coefficient (R2) was used to determine the degree of accuracy of fit between the experimental data and the model curves. A titration curve was obtained for each serum sample and, where appropriate, compared with the curve of a standard positive reference serum. The antibody titre for each individual was expressed as a reciprocal of the dilution of serum which gave an absorbance reading equivalent to one third the maximum value produced by the standard reference serum.
INHIBMON ASSAYS
Competitive inhibition was assessed using a single dilution of a serum sample. The dilution was chosen after comparing the inhibitions for serum dilutions between 1 in 20 and 1 in 160. Inhibition was at a maximum between 1 in 80 and 1 in 160 dilutions. The sera were diluted in PBS-T containing 10% polyethylene glycol (BDH Ltd) or in S-C buffer, and distributed into nine aliquots for each buffer. Eight two-fold dilutions of MCP(A + C) in PBS-T containing 10% polyethylene glycol or in S-C buffer were prepared starting at the highest concentration (100 pg/ml) and ending with the lowest concentration (0-78 pg/ml). An equal volume of a different serial dilution of MCP(A + C) was added to each of eight aliquots containing serially diluted serum; the same volume of buffer alone was added to the ninth serum aliquot as the 0% inhibition control. The serum and polysaccharide dilutions were allowed to react for one hour at 370C and antibody activity of the mixture was then determined by two ELISA procedures, as described before. rpm using a microfuge. The supernatant fluid was discarded and 1 ml of MCP(A + C)/ poly-L-lysine conjugate antigen, dialysed overnight at 4°C against NaHCO, (O lM)/ NaCl (0-5M) buffer (pH 8 3), was added. Uncoated Sepharose beads with buffer in five other tubes were used as controls. The tubes were rotated and mixed for two hours at room temperature and washed twice with NaHCOJ/NaCl buffer (pH 8 3). The supernatant fluids were discarded and the antigen and controls were washed with three cycles of alternating pH. Each cycle consisted of a wash using sodium acetate (0O 1M)/sodium chloride (IM) buffer (pH 4), followed by a wash using borate (O 1M)/NaCl (1M) buffer (pH 8). The supernatant fluid was discarded after the final wash. One milli-litre each of five serum dilutions (1 in 10, 1 in 40, 1 in 80, 1 in 160, 1 in 640 in PBS-T containing 1% BSA and 5% polyethylene glycol) was added to the antigen and control tubes; duplicate serum dilutions were stored at -20°C (as pre-adsorption sera). Adsorption was permitted at 370C for two hours on a rotor and the tubes were then centrifuged at 6500 rpm for five minutes. The supernatant fluids were stored at -20°C (post-adsorption sera). The pre-and postadsorption sera were tested by ELISA using MCP(A + C)/poly-L-lysine conjugate coating, as described before. serogroup A and then with 500 pl (1'8 x 109 bacteria) suspension of killed N meningitidis 1 serogroup C, for 30 minutes each at 37°C on a DS rotor. The Eppendorf tubes were centrifuged at 13 000 rpm for five minutes after adsorption with each bacterial strain and the supernatant fluids stored at -20°C. The pre-and post-adsorption sera were tested by ELISA using MCP(A + C)/poly-L-lysine conjugate = 1000 coating, as described before.
Results

MENINGOCOCCAL ANTIBODY TITRES
The MCP/poly-L-lysine ELISA curves for various human sera (PP, Ao, Al, and ADS) using divalent antigens ( Competitive inhibition assays, as described for the two methods, showed less than 40% inhibition of antibody activity for the prevaccination serum (Ao) with the MCP/poly-L-lysine ELISA, compared with 60% with the MCP/mHSA ELISA. However, the antibody activity of the post-vaccination serum (Al) was inhibited by 50% using the MCP/poly-Llysine ELISA, and by 90% using the MCP/mHSA ELISA (fig 2) . Antibody activity in the post-vaccination serum was reduced by 51% after adsorption with antigen-coated Sepharose beads and maximally by 59% after adsorption with suspensions of killed meningococci, confirming the reduced specificity of the MCP/poly-L-lysine ELISA.
REPRODUCIBIITIY
The MCP/poly-L-lysine ELISA gave antibody titre results that were less reproducible than the results obtained from the MCP/mHSA ELISA. The intrabatch coefficient of variation (CV) using the MCP/poly-L-lysine ELISA was 43%, while the interbatch CV was 16%.
In contrast, the CV of the MCP/mHSA was 4% (intrabatch) and 2% (interbatch). Carbohydrates, coupled with poly-L-lysine, were used as antigens for coating microtitre plates and were found to be sensitive and reproducible." This was attributed partly to the maintenance of a constant alkaline pH in the conjugation process. In our experience, the use of poly-L-lysine is sensitive but less reproducible, although an alkaline pH was also maintained during conjugation of MCP to poly-L-lysine; we found a high intrabatch coefficient of variation (43%) and an interbatch coefficient of variation of 16%. The type of microtitre plate used in the assay may also contribute to the high intrabatch variation; this was confirmed by maximal absorbance of control wells coated with the coating buffer alone. The competitive inhibition assay with the poly-L-lysine method showed 50% inhibition of antibody activity of the post-vaccination serum, indicating the presence of non-specific binding to poly-Llysine. This was also confirmed when poly-Llysine was used as antigen to coat microtitre plate wells directly for the assay or to coat Sepharose beads for adsorption before the assay. In both cases maximal binding of antibodies was observed over the entire range of serum dilutions used in the assay and up to 42% adsorption of antibody activity was achieved with poly-L-lysine (data not shown).
These observations suggest that the use of meningococcal polysaccharides, coupled with poly-L-lysine, for coating microtitre plates, can produce non-specific binding of antibodies to the polypeptides and may not be ideal in ELISA for measuring antimeningococcal antibodies. Other workers also found that poly-Llysine produced non-specific absorbance with some sera in their meningococcal ELISA.13 mHSA mixed with meningococcal polysacharides, on the other hand, showed 90% inhibition of antibody activity of post-vaccination serum. This shows minimal non-specific binding to the mHSA. We also found the use of mHSA to be more reproducible with low coefficients of variation of 4% (intrabatch) and 2% (interbatch). These figures compare with less than 10% variations reported for other validated ELISAs for measuring antibodies against encapsulated bacteria.2' Our study has shown that the use of mHSA is better than that of poly-L-lysine for coating microtitre plates in meningococcal ELISA because it is more specific and more reproducible. We were also able to measure the different immunoglobulin isotypes of human antibodies against meningococcal polysaccharides groups A and C with this method.
It has been observed that standard ELISAs measure high avidity antibodies whereas amplified ELISAs can detect low avidity antibodies.24 In our study the prolonged incubation of serum for 48 hours with the poly-L-lysine method, and for 24 hours with the mHSA method, suggests that low avidity antibodies were being detected. It was possible to reduce this serum incubation time to one hour in the poly-L-lysine method, and obtain a similar absorbance value, in the presence of 10% polyethylene glycol. 
